Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Solid Tumor 12 Carcinoma, Non-Small-Cell Lung 10 Neoplasms 6 Stomach Neoplasms 5 Melanoma 5 Carcinoma, Hepatocellular 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Solid Tumor 4 Carcinoma, Transitional Cell 4 Advanced Solid Tumors 4 Small Cell Lung Carcinoma 3 Sarcoma 3 Nasopharyngeal Carcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Liposarcoma 2 Esophageal Squamous Cell Carcinoma 2 Uterine Cervical Neoplasms 1 Solid Tumor, Adult 1 Solid Cancer 1 Recurrence 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Nasopharyngeal Neoplasms 1 Malignant Neoplasms of Digestive Organs 1 Lymphoma 1 Locally Advanced or Metastatic Solid Tumors 1 Locally Advanced or Metastatic GC and GCJ Adenocarcinoma 1

Interventions

Gemcitabine 6 Cisplatin 6 pembrolizumab 4 Docetaxel 4 Capecitabine 4 Oxaliplatin 2 Carboplatin 2 toripalimab 1 tocilizumab 1 tislelizumab 1 spartalizumab 1 cc-486 1 Injections 1 Fluorouracil 1 Dexamethasone 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Nasopharyngeal Neoplasms × toripalimab × Clear all

NCT06457503 2026-04-06

TRANSPARENT

Coherus Oncology, Inc.

Phase 4 Recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡